Mycosten (Ciclopirox)

Ciclopirox chelates intracellular metal ions, which inhibits key enzymes in the fungal sterol synthesis pathway. This blocks ergosterol production, weakening the fungal cell membrane and causing leakage of cellular contents, ultimately leading to fungal cell death at the site of application.

The dosing regimen for Mycosten is determined by the prescribing healthcare professional. Typically, a thin layer is applied to the affected area once or twice daily for a period specified by the prescriber, often ranging from two to four weeks depending on the infection.

Safety data for ciclopirox in pregnancy and lactation are limited. The product’s pregnancy category is not established, so it should only be used if the potential benefit justifies the potential risk. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their healthcare provider.

To place an order, submit an enquiry on the Mycosten product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Mycosten (ciclopirox) belongs to a non‑azole class of topical antifungals, offering a different mechanism of action than azole agents such as clotrimazole or terbinafine. This can be advantageous in cases of azole‑resistant organisms or when patients experience irritation from azole formulations. Efficacy is comparable for many dermatophyte infections, but choice depends on clinician preference and patient tolerance.

Store Mycosten at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme heat. Keep the container tightly closed when not in use and out of reach of children.

Mycosten is applied topically to clean, dry skin or nail surfaces. A thin film should be spread over the affected area, gently massaging it in. For nail infections, the medication may be applied to the nail plate and surrounding skin as directed by the prescriber.

Although uncommon, serious adverse reactions can include allergic contact dermatitis, severe skin irritation, swelling, blistering, urticaria and, in rare cases, anaphylaxis. If any of these symptoms develop, discontinue use immediately and seek medical attention.

Mycosten should be avoided in individuals with known hypersensitivity to ciclopirox or any of the product’s excipients. It is also contraindicated on severely damaged skin, open wounds, or mucous membranes such as the eyes and mouth. Patients with a history of severe allergic skin reactions should consult a healthcare professional before use.